Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases - PubMed (original) (raw)
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases
S I Rennard et al. Proc Natl Acad Sci U S A. 1981 Nov.
Abstract
Because cells of the mononuclear phagocyte system are known to produce fibronectin and because alveolar macrophages are activated in many interstitial lung diseases, the present study was designed to evaluate a role for the alveolar macrophage as a source of the increased levels of fibronectin found in the lower respiratory tract in interstitial lung diseases and to determine if such fibronectin might contribute to the development of the fibrosis found in these disorders by being a chemoattractant for human lung fibroblasts. Production of fibronectin by human alveolar macrophages obtained by bronchoalveolar lavage and maintained in short-term culture in serum-free conditions was demonstrated; de novo synthesis was confirmed by the incorporation of [14C]proline. This fibronectin had a monomer molecular weight of 220,000 and was antigenically similar to plasma fibronectin. Macrophages from patients with idiopathic pulmonary fibrosis produced fibronectin at a rate 20 times higher than did normal macrophages; macrophages from patients with pulmonary sarcoidosis produced fibronectin at 10 times the normal rate. Macrophages from 6 of 10 patients with various other interstitial disorders produced fibronectin at rates greater than the rate of highest normal control. Human alveolar macrophage fibronectin was chemotactic for human lung fibroblasts, suggesting a functional role for this fibronectin in the derangement of the alveolar structures that is characteristic of these disorders.
Similar articles
- Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.
Rennard SI, Crystal RG. Rennard SI, et al. J Clin Invest. 1982 Jan;69(1):113-22. doi: 10.1172/jci110421. J Clin Invest. 1982. PMID: 7054232 Free PMC article. - Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes.
Uebelhoer M, Bewig B, Sternberg K, Rabe K, Nowak D, Magnussen H, Barth J. Uebelhoer M, et al. Lung. 1995;173(3):187-95. doi: 10.1007/BF00175659. Lung. 1995. PMID: 7616760 - Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.
Bitterman PB, Wewers MD, Rennard SI, Adelberg S, Crystal RG. Bitterman PB, et al. J Clin Invest. 1986 Mar;77(3):700-8. doi: 10.1172/JCI112364. J Clin Invest. 1986. PMID: 3081573 Free PMC article. - The alveolar macrophage.
Bowden DH. Bowden DH. Environ Health Perspect. 1984 Apr;55:327-41. doi: 10.1289/ehp.8455327. Environ Health Perspect. 1984. PMID: 6376105 Free PMC article. Review. - [Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia].
Suga M, Iyonaga K, Ando M. Suga M, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:175-80. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 9216211 Review. Japanese.
Cited by
- Osteopontin and fibronectin in lung tissue, serum, and bronchoalveolar lavage fluid of dogs with idiopathic pulmonary fibrosis and control dogs.
Fastrès A, Roels E, Tutunaru AC, Bolen G, Merveille AC, Day MJ, Garigliany MM, Antoine N, Clercx C. Fastrès A, et al. J Vet Intern Med. 2023 Nov-Dec;37(6):2468-2477. doi: 10.1111/jvim.16870. Epub 2023 Oct 18. J Vet Intern Med. 2023. PMID: 37853926 Free PMC article. - Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
Hong SY, Lu YT, Chen SY, Hsu CF, Lu YC, Wang CY, Huang KL. Hong SY, et al. Cell Death Dis. 2023 Jun 8;14(6):352. doi: 10.1038/s41419-023-05876-z. Cell Death Dis. 2023. PMID: 37291088 Free PMC article. - Remarkable sex-specific differences at single-cell resolution in neonatal hyperoxic lung injury.
Cantu A, Gutierrez MC, Dong X, Leek C, Sajti E, Lingappan K. Cantu A, et al. Am J Physiol Lung Cell Mol Physiol. 2023 Jan 1;324(1):L5-L31. doi: 10.1152/ajplung.00269.2022. Epub 2022 Oct 25. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36283964 Free PMC article. - Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues.
Dooling LJ, Saini K, Anlaş AA, Discher DE. Dooling LJ, et al. Matrix Biol. 2022 Aug;111:153-188. doi: 10.1016/j.matbio.2022.06.006. Epub 2022 Jun 25. Matrix Biol. 2022. PMID: 35764212 Free PMC article. Review. - Early skeletal muscle pathology and disease progress in the dy3K/dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency.
Gawlik KI, Körner Z, Oliveira BM, Durbeej M. Gawlik KI, et al. Sci Rep. 2019 Oct 4;9(1):14324. doi: 10.1038/s41598-019-50550-0. Sci Rep. 2019. PMID: 31586140 Free PMC article.
References
- Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
- Coll Relat Res. 1981;1(1):95-128 - PubMed
- J Lab Clin Med. 1973 Sep;82(3):522-8 - PubMed
- Biochem Biophys Res Commun. 1976 SEP 20;72(2):426-32 - PubMed
- J Exp Med. 1976 Nov 2;144(5):1188-203 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical